The new Mounjaro pen now appearing in the UK looks familiar, but its internal design has changed. Eli Lilly has modified the KwikPen mechanism so the plunger sits differently and less liquid remains visible after dose four. The medicine, strengths and weekly dosing schedule themselves have not changed in practice.
This guide shows you what to look for when comparing the new Mounjaro pen with the older version. We cover the visible plunger differences, how the four-dose pen works, why leftover liquid may appear reduced, and what the redesign means for patients receiving the modified Mounjaro KwikPen in the UK.
Key Insights About the Modified Mounjaro Pen
- ✔The new Mounjaro pen looks similar externally, but its internal plunger mechanism has been redesigned.
- ✔The modified pen has a thicker, extended black plunger that starts further down the cartridge.
- ✔After dose four, considerably less residual liquid is visible than with the previous KwikPen.
- ✔The medicine itself has not changed: tirzepatide, available strengths and the four-dose weekly schedule remain the same.
- ✔Any leftover liquid is not an authorised “fifth dose” and should not be extracted or used.
- ✔UK patients may receive either pen design during the stock transition, so the supplied instructions should always be followed.
GLP-1 / GIP
Mounjaro
Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
- ✔~22.5% average body weight loss
- ✔Significant weight reduction
- ✔Improves blood sugar levels
- ✔Clinically proven weight loss
What Does the New Mounjaro Pen Look Like?
The new Mounjaro pen closely resembles the previous KwikPen, retaining its familiar shape, dose dial and colour-coded labelling. Changes are mainly visible through the cartridge, where the plunger differs in size, starting position and final position after dose four.
Thicker Black Plunger
The modified Mounjaro KwikPen has a thicker black plunger with an additional extension behind it, giving the internal mechanism a longer appearance than the previous version. This is an intentional feature of the updated pen and does not indicate damage or a manufacturing fault.
Lower Plunger Position
In the new style Mounjaro pen, the plunger starts further down the cartridge. As a result, a new pen may appear to contain less liquid at first glance, but it still contains enough solution for all four prescribed doses and the required priming.
Less Liquid After Dose Four
The plunger travels further through the cartridge as each weekly dose is given. After the fourth injection, it finishes much nearer the end, leaving considerably less visible liquid than before. This reduces the residual fluid sometimes called the “golden dose”, although any remainder is not an authorised additional dose.
How Can You Tell If You Have the New Mounjaro Pen?
The easiest way to identify the new Mounjaro pen is through the cartridge window, where the modified version can be recognised by the plunger’s different position and appearance. Outer labelling and product codes do not distinguish the two versions, so the internal mechanism offers the clearest clue.
Check the instructions supplied with your pen, as the parts diagram corresponds to the device inside. If you remain unsure, ask your pharmacy or treatment provider to confirm the version supplied.
| Visual Feature | Previous KwikPen | Modified KwikPen |
|---|---|---|
| Plunger design | Original mechanism | Thicker, extended mechanism |
| Starting position | Higher in the cartridge | Further down the cartridge |
| After dose four | More residual liquid may be visible | Considerably less liquid is visible |
| Outer labelling | Existing colour-coded design | Essentially unchanged |
Both designs may remain in circulation while UK stock transitions to the modified pen.
What Has Stayed the Same With the New Mounjaro Pen?
The Mounjaro new pen design changes the internal device rather than the treatment. Receiving the modified version does not require a different dose schedule, injection technique or strength simply because the pen itself looks different.
| Feature | What Remains the Same |
|---|---|
| Medicine | The active ingredient remains tirzepatide at the same concentration for each prescribed strength. |
| Doses per pen | Each KwikPen provides four fixed 0.6 ml doses, taken once weekly. |
| Available strengths | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg remain available. |
| Injection method | Priming, dialling and administering the dose follow the same process. |
| Storage | Unused pens should be refrigerated at 2°C–8°C; an in-use pen may be kept below 30°C for up to 30 days. Read our guide to Mounjaro pen storage for detailed UK guidance on storage, expiry and safe handling. |
| Product codes | GTIN and PIP codes remain unchanged, so pharmacy ordering and prescribing are unaffected. |
| Disposal | The pen should still be discarded appropriately after its four intended doses. |
What About the ‘Golden Dose’ or ‘Fifth Dose’?
The terms “golden dose” and “fifth dose” describe liquid left in a Mounjaro KwikPen after the four prescribed weekly injections. This extra solution is intentionally included to support priming and ensure four complete 0.6 ml doses can be delivered. It was never designed or measured as an additional injection.
Not a Fifth Dose
The remaining fluid is a device buffer rather than an authorised dose. Its quantity cannot be relied upon to provide an accurate injection, so attempting to extract it may result in uncertain dosing. Mounjaro KwikPens should therefore be used only for the four doses specified in the manufacturer’s instructions.
Safety Risks
Accessing leftover medicine usually requires using the pen outside its intended design, which may compromise sterility and increase contamination or infection risk. The pen should also be discarded within 30 days of first use, even if some solution remains, in line with the manufacturer’s storage and usage guidance.
New Pen Difference
The updated design leaves substantially less residual liquid once the fourth injection has been completed. This is why it is sometimes described as the new Mounjaro pen without a golden dose, although a small residue may remain and should never be used as another injection.
If you still have questions about Mounjaro, start a free online consultation for personalised guidance from a qualified UK prescriber.
Why Has Eli Lilly Changed the Mounjaro Pen?
Eli Lilly updated the KwikPen to make completion of its intended four-dose cycle clearer for patients. Reducing visible residual liquid also helps remove uncertainty about whether another usable injection remains after the fourth dose.
This clearer end point may discourage attempts to withdraw residual medicine that was never intended as an additional measured dose. The new Mounjaro pen also brings the UK device closer to versions already used in markets such as the US and Germany.
Conclusion: Recognising the New Mounjaro Pen Design
The new Mounjaro pen may look different through the cartridge, but the treatment itself remains unchanged. Understanding the revised plunger and clearer end point makes the modified KwikPen easier to recognise. Patients should follow the instructions supplied with their device and never treat residual liquid as an additional prescribed dose.
For patients prescribed Mounjaro, Online Weight Loss Clinic provides UK prescriber-led treatment with discreet home delivery and ongoing support throughout treatment. Patients can receive guidance on using their prescribed pen correctly, managing dose progression and understanding device changes, helping them stay informed as the modified Mounjaro KwikPen becomes more widely available.
FAQs about the new Mounjaro pen
When did the new Mounjaro pen arrive in the UK?
The modified KwikPen began entering UK supply from April 2026, with stock changing over gradually rather than on one fixed date. Availability can therefore vary between pharmacies and treatment providers.
Do I need a new prescription for the modified Mounjaro pen?
No separate prescription is generally required solely because of the device redesign. The GTIN and PIP codes remain unchanged, and existing prescriptions continue to cover the prescribed Mounjaro strength as stock moves to the modified pen.
Can I request the new Mounjaro pen from my pharmacy?
You can ask your pharmacy which version it currently holds, but the modified design may not always be available on request. During the transition, dispensing depends on existing pharmacy and distributor stock.
Does the new Mounjaro pen need different needles?
No special needle has been introduced specifically for the redesigned pen. The KwikPen uses compatible pen needles, and a new needle should be used for each injection.
Do the lines on the Mounjaro cartridge show how many doses are left?
No. The markings visible on the cartridge are not dose indicators and should not be used to estimate how many injections remain. Follow the dose window and supplied instructions for use instead.
What should the liquid inside a Mounjaro pen look like?
Mounjaro should appear clear and colourless to slightly yellow. Do not use the pen if the medicine looks cloudy, discoloured or contains visible particles.
What should I do if my new Mounjaro pen looks damaged?
Do not use a pen that appears damaged or has a compromised inner seal. Check the supplied instructions and contact your pharmacist or treatment provider if you are uncertain whether the device is safe to use.
How can I report a problem with a Mounjaro pen in the UK?
Speak to your pharmacist or prescriber if you believe the pen is faulty or has not worked correctly. Suspected medicine or device problems can also be reported to the MHRA through the Yellow Card scheme.
